Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-649266 versus imipenem/cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis
2014-000914-76Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cefiderocol in complicated urinary tract infection (cUTI), pyelonephritis, acute pyelonephritis and 1 more (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Primary efficacy endpoint. Started Aug 2014; status: completed.
02
Drugs
cefiderocol
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritisacute pyelonephritisGram-negative bacterial infection
Beyond the preview
Go deeper on 2014-000914-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000914-76.